相关实验视频

Updated: Sep 13, 2025

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

在BALB/c小鼠模型中,CRISPR/Cas9降低了眼睛疹感染的病毒载荷

Luiza Silveira Garcia¹, Rafaela Moraes Pereira de Sousa¹, Viviane Souza Campos²

¹Laboratório de Virologia e Parasitologia Molecular, Instituto Oswaldo Cruz/FIOCRUZ, Rio de Janeiro 21040900, RJ, Brazil.

|July 29, 2025

概括

在一只小鼠模型中,CRISPR/Cas9基因编辑有效降低了简单疹病毒1型 (HSV-1) 病毒载量和眼部病变. 这表明CRISPR/Cas9作为疹性角膜炎的潜在替代疗法.

科学领域:

眼科医生眼科眼科
分子生物学分子生物学
基因治疗基因治疗

背景情况:

由HSV-1引起的疹性角膜炎是感染性失明的主要原因.
目前对HSV-1的治疗方法可能导致毒性或耐药性,需要替代疗法.
对于那些对传统治疗没有反应的严重病例,可能需要进行角质整形.

研究的目的:

评估CRISPR/Cas9作为针对HSV-1的替代疗法的疗效.
在实验性眼部疹模型中评估CRISPR/Cas9的抗病毒活性.

主要方法:

在使用HSV-1的BALB/c小鼠中建立了疹性角膜炎的实验模型.
对受感染的小鼠进行了CRISPR/Cas9基因编辑疗法.
病毒载量和眼部损伤得分被量化,并在治疗和未治疗组之间进行了比较.

主要成果:

用HSV-1接种的小鼠显示病毒载量的剂量依赖性增加.
克里斯普尔/卡斯9治疗显著降低HSV-1病毒载量2 log$_{10}$副本/毫升 (p ≤ 0.0001).
与对照组相比,CRISPR/Cas9也导致了眼睛损伤得分的显著降低.

结论:

在眼部感染模型中,CRISPR/Cas9显示出针对HSV-1的显著抗病毒活性.
这些发现支持进一步研究CRISPR/Cas9作为疹性角膜炎的新疗法策略.
基因编辑为治疗耐药或有毒眼疹病例提供了一个有希望的途径.

关键词:

这就是CRISPR/Cas9的作用.在HSV-1病毒中,疹性角膜炎是一种疹性角膜炎.在体内模型的 in vivo 模型.

更多相关视频

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing

Published on: January 7, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...